<?xml version="1.0" encoding="UTF-8"?>
<p>Although history teaches us that vaccination is the most effective and powerful method to combat effects of epidemics, the availability of antiviral drugs is also very useful, especially for slowing the spread of new pandemic viruses, thus allowing producers to prepare large quantities of pandemic vaccine. In this perspective, the possibility of developing new antiviral drugs represents a need felt by the whole scientific world and the opportunity that is granted to us by use of natural sources is truly valuable. Traditional or conventional methods have supplied the herbal preparations to the pharmaceutical industries, and this will guarantee a growth in this production by ensuring new principles for the fight against virus-derived diseases [
 <xref rid="B7-pharmaceuticals-14-00381" ref-type="bibr">7</xref>,
 <xref rid="B183-pharmaceuticals-14-00381" ref-type="bibr">183</xref>,
 <xref rid="B184-pharmaceuticals-14-00381" ref-type="bibr">184</xref>]. The initial development of the antiviral drugs was done by European researchers right after the Second World War. It was led by Boots Drug Company from England that examined the action of 288 plants and their respective phytoconstituents against influenza A virus, and at the end of the investigation, 12 plants showed suppressing effects [
 <xref rid="B185-pharmaceuticals-14-00381" ref-type="bibr">185</xref>].
</p>
